- Home
- App Analytics
- ESCV 2023
- ESCV 2023 Vs. Immuno-Oncology
ESCV 2023 vs Immuno-Oncology Usage & Stats
In the official congress app you will find: the updated program, speakers, useful information and all the details of the upcoming 25th ESCV Annual Meeting
- Apple App Store
- Free
- Medical
Store Rank
- -
@Point of Care™ with Ask Cognitive AI is a clinical decision-making mobile platform. Immuno-Oncology @Point of Care™ provides a streamlined clinical decision support tool for clinicians to obtain content when it is needed—enabling better decisions, better outcomes, and better care.
With Ask Cognitive AI, clinicians use @Point of Care™ to easily access curated, evidence-based, and disease-specific medical content. Clinicians navigate content by asking voice-enabled natural language questions. Cognitive AI provides confidence-rated answers to efficiently incorporate best treatment options happen more quickly and decisions are made faster to improve patient outcomes at the point of care.
Immuno-Oncology @Point of Care™ is designed to:
• Support discovery and practice change
• Provide relevant, evidence-based disease-specific medical content
• Improve patient outcomes at the point of care
Features:
• Continually updated Immuno-Oncology content
• Customize your library with over 50 supplemental topics
• Topics in diagnosis, treatment, and care management developed with expert physician authors
• Case studies, videos, and interviews
• Access to actionable patient-recorded data
• Detailed reference list with access to original sources
• Continuing medical education credit (CME/CE)
• Surveys and peer polling
• Patient education resources to share with patients
- Apple App Store
- Free
- Medical
Store Rank
- -
ESCV 2023 vs. Immuno-Oncology ranking comparison
Compare ESCV 2023 ranking trend in the past 28 days vs. Immuno-Oncology
Rank
No Data Available
ESCV 2023 vs. Immuno-Oncology ranking by country comparison
Compare ESCV 2023 ranking trend in the past 28 days vs. Immuno-Oncology
No Data to Display
Compare to any site with our free trial
ESCV 2023 VS.
Immuno-Oncology
December 16, 2024